Related to Clinical Genomics Nabs Enterix, Aims to Launch New Bowel Cancer Blood Test

• Parsing the Phenome
  Using metabolic phenotyping approaches, researchers are deconstructing gene-environment interactions and their contributions to disease risk at the personal and population scales.
  
• Drug Candidates on Trial
  A list of recent clinical trials for drugs in development.
  
• New Gene Patent Suit Sparks Talk of Trolls
  The BRACAnalysis developer is poised to spawn a Myriad of lawsuits.
  
• Improving Preclinical Research
  The surest way to bring new drugs to market is also the most obvious—making certain they work before they reach the clinic.
  
• Literature Review: New Combination of Targets Shows Promise for Leukemia
  Researchers looked at the combination of a CHK1 inhibitor and an HDAC inhibitor for their effect on AML cells.
  
• Eye on Cancer Biomarkers
  This insightful analysis of publications shows research trends and putative signatures for different cancer types.
  
• Cancer Biomarkers: Your Questions Answered
  Enal Razvi, Ph.D., replies to all comments posted in his report 'Eye on Cancer Biomarkers'
  
• As Big Deals Resurface, Who’s Next to the Altar?
  Amgen-Onyx, Perrigo-Elan warm an M&A space that had been chilled by an IPO revival.
  
• Takeover Targets: Who Is First on the List?
  Which companies are next in acquisition alley?
  
• Literature Review: Probing Protein Oligomerization
  Researchers describe an assay to measure the allosteric effects of synthetic peptides on self-oligomerization of AGR2 protein.
  
• Ovarian Cancer Treatment Options Multiply
  Vaccines and PARP inhibitors are among the promising emerging therapies.
  
• 2009 in Review: Headline-Making Stories in the Biotech Industry
  Even though last year was marred by the economic crash, the life science sector showed significant progress.
  
• Getting Personal: Multigene Testing for Individual Cancer Evaluation
  Scientists find comfort in numbers, using molecular patterns as prognostic markers.
  
• Tumor Cells Back in Circulation for Monitoring Cancer
  With one test on the market, researchers are developing tools that leverage CTCs as biomarkers.
  
• Genome Testing Reduces Overtreatment
  Study after study has shown that molecular diagnostics can help oncologists more effectively treat patients.
  
• 7 Biotech Trends for the Coming Year
  What does 2013 hold for the industry?
  
• 10 Predictions That Will Transform Healthcare
  Peer into GEN's crystal ball for a glimpse of what's to come.
  
• Detecting Acquired Drug Resistance in Cancer
  New methods allow noninvasive analysis in blood plasma.
  
• Moving Genomics Closer to the Clinic
  Foundation Medicine and Memorial Sloan-Kettering Cancer Center are working to translate genomic information into personalized cancer treatment.
  
• Gene Test Boom Faces Lawsuits
  Testing giant and two rivals clash in court, threatening to cloud a sunny growth forecast.